Butantan Has Been Waiting for 9 Months for Anvisa's Approval to Study Avian Flu Vaccine in Humans

By Patrícia Pasquini (Folhapress) The Butantan Institute, located in the western part of São Paulo, has been waiting for nine months for approval from Anvisa (the National Health Surveillance Agency) to begin clinical studies for the development of a vaccine against avian flu – influenza type A H5N8 (fragmented, inactivated and adjuvanted). The request to the agency was sent […]